Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 2 , Pages 93-100 , February 2010

Metabolic syndrome in primary aldosteronism and essential hypertension: Relationship to adiponectin gene variants

Received 13 November 2008 ,Revised 13 February 2009 ,Accepted 2 March 2009.

References 

  1. Funder JW. The nongenomic actions of aldosterone. Endocr Rev. 2005;26:313–321
  2. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, et al. PAPY study participants. Renal damage in primary aldosteronism: results of the PAPY study. Hypertension. 2006;48:232–238
  3. Giacchetti G, Sechi LA, Rilli S, Carey RM. The renin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab. 2005;16:120–126
  4. Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab. 2008;19:88–90
  5. Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, et al. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab. 2006;91:454–459
  6. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Prately RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–1935
  7. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y. Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens. 2003;16:72–75
  8. Daniele A, Cammarata R, Pasanisi F, Finelli C, Salvatori G, Calcagno G, et al. Molecular analysis of the adiponectin gene in severely obese patients from Southern Italy. Ann Nutr Metab. 2008;53:155–161
  9. Vasseur F, Helbecque N, Dina C, Lobbens S, Delannoy V, Gaget S, et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocytes-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet. 2002;11:2607–2614
  10. Giacchetti G, Ronconi V, Lucarelli G, Boscaro M, Mantero F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens. 2006;24:737–745
  11. National Cholesterol Education Program (NCEP) Expert Panel on Detection . Evaluation and treatment of high blood cholesterol in adults: executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:246–249
  12. Milliez P, Girerd X, Plouin PE, Blacher J, Safar ME, Mourad JJ. Evidence of an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243–1248
  13. Bo S, Gentile L, Ciccone G, Baldi C, Benini L, Dusio F, et al. The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort. Diabetes Metab Res Rev. 2005;21:515–524
  14. Feder ME. Evolvability of physiological and biochemical traits: evolutionary mechanisms including and beyond single-nucleotide mutation. J Exp Biol. 2007;210:1653–1660
  15. Yang SW, Chuang LM. Human genetics of adiponectin in the metabolic syndrome. J Mol Med. 2006;84:112–121
  16. Yang WS, Tsou PL, Lee WJ, Tseng DL, Chen CL, Peng CC, et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med. 2003;81:428–434
  17. Ukkola O, Ravussin E, Jacobson P, Sjostrom L, Bouchard C. Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism. 2003;52:881–884
  18. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes. 2002;51:2306–2312
  19. Xita N, Georgiou I, Chatzikyriakidou A, Vounatsou M, Papassotiriou GP, Papassotiriou I, et al. Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem. 2005;51:416–423
  20. Filippi E, Sentinelli F, Trischitta V, Romeo S, Arca M, Leonetti F, et al. Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet. 2004;12:199–205
  21. Zacharova J, Chiasson JL, Laakso M. The common polymorphisms (single nucleotide polymorphisms SNP+45 and SNP+276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM Trial. Diabetes. 2005;54:893–899
  22. Hu FB, Doria A, Li T, Meigs JB, Liu S, Memisoglu A, et al. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes. 2004;53:209–213
  23. Giacchetti G, Ronconi V, Turchi F, Agostinelli L, Mantero F, Rilli S, et al. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens. 2007;25:177–186
  24. Fallo F, Della Mea P, Sonino N, Bertello C, Ermani M, Vettor R, et al. Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens. 2007;20:855–861
  25. Debard C, Laville M, Berbe V, Loizon E, Guillet C, Morio-Liondore B, et al. Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of type 2 diabetic patients. Diabetologia. 2004;47:917–925
  26. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26:439–451

PII: S0939-4753(09)00063-5

doi: 10.1016/j.numecd.2009.03.007

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 2 , Pages 93-100 , February 2010

Article Tools

* Image Usage & Resolution